Slide 1: Form 6-K cover
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of September 2006 (September 20, 2006) Commission File Number: 0-15850 ANSELL LIMITED (Translation of regis
Slide 2: Ansell Limited Business Overview - September 2006
Ansell Limited Business Overview - September 2006 Doug Tough – Chief Executive Officer Rustom Jilla – Chief Financial Officer 1
Slide 3: Agenda
Agenda 1. Overview - Doug Tough 2. Results - Rustom Jilla 3. Strategic Focus - Doug Tough FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended, and information that is based on management’s beliefs as we
Slide 4: Overview
Overview Doug Tough 3 3
Slide 5: Who is Ansell?
Who is Ansell? A 101+ year old company A world leader in healthcare barrier protection products and services An Australian (ASX) listed Company (ANN), with market capitalization ~US$1.1 billion (~GBP590 million) Sales of ~US$850 million (~GBP450 million) and over 11,000 employees in 26 countries Sta
Slide 6: A Global Leader
A Global Leader Estimated global market size and positions Surgical Gloves Occupational Gloves (Synthetics) Market: ~US$0.6B ~ ~ Market: ~US$2.1B ~ ~ 2006 2006 #2 Ansell ~ 24% #1 Ansell ~20% Exam Gloves (Excluding Consumer (Condoms) Occupational) ~ ~ Market: ~US$0.9B ~ Market: ~US$1.0B ~ 2006 2006 #
Slide 7: Our Products
Our Products 6
Slide 8: Diversified Key Customers
Diversified Key Customers Companies: industrial, auto, chemicals, food etc. Hospitals/Medical Centres; acute and alternate care, first responders etc Retail: food stores, drug stores, convenience stores, mass merchandisers 7
Slide 9: Ansell Regions – F'06
Ansell Regions – F’06 SALES ($M) = 849.1 16% SEGMENT EBIT ($M) = 107.6 Asia Pacific 133.2 25% 43% Asia Pacific 27.3 Americas Europe 46.4 Americas 313.7 Europe 402.2 33.9 47% 37% 32% 8
Slide 10: Manufacturing Facilities
Manufacturing Facilities India & Sri Lanka Standard & Premium Surgical Condoms Powder Free Exam General Purpose Chemical Resistant Outsource ~US$150 M Critical Environment Americas & UK Exam gloves Occupational gloves Chemical Resistant General Purpose Specialty High spec knitted Employees (11,000 a
Slide 11: Results
Results Rustom Jilla 10
Slide 12: Total Shareholder Return
Total Shareholder Return F’06 TSR -1% 12 F’04 F’05 12 11.5 TSR 34% TSR 32% 11.5 11 11 AUD +64% AUD 10.5 $10.04 10.5 10 10 9.5 $9.67 9.5 9 9 8.5 $7.74 $7.65 8.5 8 USD 8 USD +80% 7.5 7.5 7 $5.90 7 $7.18 6.5 6.5 $5.35 6 6 5,074 5.5 5.5 ASX200 +67% 5 $3.99 ASX 200 5 4.5 4,278 4.5 4 3,533 4 3.5 3,039 3.5
Slide 13: Key Financial Metrics
Key Financial Metrics F’05 F’06 Sales $M 812.1 849.1 +4.6% despite USD headwinds Profit Attributable $M 101.0 90.8 DTA Free Cash Flow 94.5 76.7 Average WC days from 85 to 80 Gross Margin % 40.1 37.4 Latex, sales mix EBIT % 13.5 12.1 Gearing % 19.1 10.8 After SPT sale, buybacks, dividends ROA (HC onl
Slide 14: Latex Cost Graph … Updated
Latex Cost Graph … Updated Source: Malaysian Rubber Board Statistics Malaysian ‘00 MYR (per wet kg) 7.00 F’07 start price 6.00 Latex Prices was MYR 6.81 +7% in F’05 Price on Sept 12 5.00 +73% in F’06 was MYR 3.85 – down 57% from 4.00 July 1 price 3.00 2.00 1.00 '86 '87 '88 '89 '90 '91 '92 '93 '94 '9
Slide 15: Occupational Business
Occupational Business 50% of Revenue and 56% of Segment EBIT $M F’05 F’06 HyFlex® 75.2 87.0 VOL +17% Knitted 47.5 46.8 VOL -9%, ASP +9% Disposables 81.3 81.9 Natural Latex 13% All Other 205.8 208.9 Synthetic 87% Sales 409.8 424.6 +3.6% Segment EBIT 61.0 60.7 Margin Erosion / Mix EBIT/Sales 14.9% 14.
Slide 16: Professional Business
Professional Business 34% of Revenue and 27% of Segment EBIT $M F’05 F’06 Surgeons: Branded PF 70.1 71.7 EMEA and AP growth Powdered 65.3 60.2 EMEA up, AM and AP down Synthetic 14.7 16.2 Strong volume growth; all regions Other 3.6 4.1 Exam: PF 68.7 77.2 VOL +19%, ASP -6% Powdered 12.3 13.5 VOL +10%
Slide 17: Consumer Business
Consumer Business 16% of Revenue and 17% of Segment EBIT $M F’05 F’06 Condoms: Branded 70.3 72.1 Jissbon $3.1M, EU +8%, AM -14% Retail Bid / Public 26.7 31.5 Tenders up, AM Public Sector Down HHG 19.2 19.0 Other 9.8 12.9 4Play & Supplements Sales 126.0 135.5 +7.5% Segment EBIT 22.0 17.9 US Retail Ma
Slide 18: Ansell's Financial Overview
Ansell’s Financial Overview Ansell had mixed results in F’06 after several strong years, but continues to have solid fundamentals: Operationally: Sales growth was the highest in 8 years while EBIT was pulled down by latex Margins of “Non-latex” products, which account for 52% of sales, remained stro
Slide 19: Strategic Focus
Strategic Focus Doug Tough 18
Slide 20: Strategic Evolution
Strategic Evolution From meeting multi-year Segment EBIT commitments to advancing Ansell Growth Strategy for F’07 and Beyond Methodology: F’06 Base Synthetic Surg China Technical Jissbon Excite™ Mexico Partnerships AlphaTEC™ India Other Channels Russia 19
Slide 21: Geographic Expansion
Geographic Expansion • Ansell’s growth in “Emerging” markets Russia Occupational +70% Central & & CIS Consumer +15% Eastern Europe Occupational +50% China Professional +37% Consumer +66% Consumer +10% Occupational +80% Latin America Occupational +29% South Africa Professional +60% Jissbon Acquisitio
Slide 22: Ansell Takeaway
Ansell Takeaway Solid and steadily growing company: - Organically - Geographically - Acquisitively Cost components tightly managed Diverse portfolio of brands, businesses, geographies Strong financial position with investment and share buy- back capability 21
Slide 23: ANSELL LIMITED
ANSELL LIMITED 22
Slide 24: Signature
SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ANSELL LIMITED (Registrant) By: /s/ DAVID M. GRAHAM Name: DAVID M. GRAHAM Title: GENERAL MANAGER – FINAN